iiinova — where your digital self keeps evolving

Krister Kauppi - Rapamycin Longevity Lab @kristerkauppi.bsky.social · 22/07/2025

Thrilled to be speaking at the Reverse Aging Summit on September 5 in beautiful Costa Rica. My topic for the talk is "Beyond Rapamycin: Advancing mTOR inhibition and combinational therapies for radical life extension". Let's meet if you are going there. Get your ticket at reverseagingsummit.org

040

Reposted by Krister Kauppi - Rapamycin Longevity Lab

Peter Ottsjö @peterottsjo.bsky.social · 22/04/2025

Bryan Johnson gave up on rapamycin. Krister Kauppi’s just getting started. ”Bryan has interpreted the study wrong and this can happen to all of us from time to time.” Check out my interview with @kristerkauppi.bsky.social! reachlevity.com/p/he-s-chasi...

reachlevity.com

He's chasing the next rapamycin

Rapamycin's next frontier: Inside the groundbreaking longevity drug screening project that's pushing the boundaries of anti-aging science and research innovation.

061

Krister Kauppi - Rapamycin Longevity Lab @kristerkauppi.bsky.social · 04/02/2025

I have now registered for one of the biggest longevity conferences in the world ARDD. It will take place at the end of August in Copenhagen in Denmark. I was there last year and there were lots of great people and talks. So I’m looking forward to more of that. Who is planning to go there as well?

050

Krister Kauppi - Rapamycin Longevity Lab @kristerkauppi.bsky.social · 01/12/2024

Time to start building the longevity movement on Bluesky 🙏

2121

Krister Kauppi - Rapamycin Longevity Lab @kristerkauppi.bsky.social · 27/11/2024

Oskar Matti has done a really great job in adding more data to the Longevity Intervention Database (LID). So now we have all the data from the ITP in both mice and worms in one place. We also have data on calorie restriction, fasting, exercise, trametinib and senolytics. masteronething.com/lid

050

Krister Kauppi - Rapamycin Longevity Lab @kristerkauppi.bsky.social · 23/04/2024

I have added longevity physician Terry Grossman to the male edition of the list of longevity leaders who take Rapamycin.

090

Krister Kauppi - Rapamycin Longevity Lab @kristerkauppi.bsky.social · 01/04/2024

I'm happy to announce that the Rapamycin Longevity Lab makes a discovery of a new potent mTOR inhibitor.

030

Krister Kauppi - Rapamycin Longevity Lab @kristerkauppi.bsky.social · 26/03/2024

Last month Ajla Hodzic Kuerec, Deborah Lee and Andrea Maier published a very interesting systematic review of Rapamycin and rapalogs (pubmed: 38310895).

060

Krister Kauppi - Rapamycin Longevity Lab @kristerkauppi.bsky.social · 23/03/2024

It’s time for an update of the list of longevity leaders who take Rapamycin.

021

Krister Kauppi - Rapamycin Longevity Lab @kristerkauppi.bsky.social · 12/03/2024

Getting old, suffer and die really sucks! On top of that life is way too short. So last month I started to think about what simple actions people can take to support the research and progress around radical life extension. I ended up with these five actions.

040

Krister Kauppi - Rapamycin Longevity Lab @kristerkauppi.bsky.social · 02/03/2024

Life is way too short and therefore one of my main life goals is to increase the odds in radically extending it. One of many steps in that direction is to set up strategies on how to achieve this. So I started to sketch on it and came up with roughly 5 potential strategies to radically extend life.

020

Krister Kauppi - Rapamycin Longevity Lab @kristerkauppi.bsky.social · 27/02/2024

It’s time to fill the Longevity Intervention Database (LID) with more data. Last time I added all the mice data from the ITP (Intervention Testing Program) to it. Now it’s time to take the next step and add all the CITP (Caenorhabditis Intervention Testing Program) data to the database.

010

Krister Kauppi - Rapamycin Longevity Lab @kristerkauppi.bsky.social · 06/02/2024

Launch of the Longevity Intervention Database (LID) to store longevity intervention data in one place. Step by step we will add more data and functionality to the page. First out ITP data.

010

Krister Kauppi - Rapamycin Longevity Lab @kristerkauppi.bsky.social · 05/12/2023

The ITP (Intervention Testing Program) is the gold standard for yearly testing of different longevity interventions in mice. The research team has recently published their yearly results (pubmed: 38041783) and it did not impact the current top list much that I have presented before.

020

Krister Kauppi - Rapamycin Longevity Lab @kristerkauppi.bsky.social · 25/11/2023

I will soon interview one of the world’s leading Rapamycin researchers Joan Mannick in the Rapamycin Longevity Series podcast. She has made and is making a huge contribution to the field with her research around the next generation of mTOR inhibitors. Are there any questions you want me to ask her?

120

Krister Kauppi - Rapamycin Longevity Lab @kristerkauppi.bsky.social · 21/11/2023

The longevity physician Sajad Zalzala from the company AgelessRx has been added to the list of longevity leaders who take Rapamycin. He is taking 6 mg of Rapamycin once every week. He is also the person who is leading the biggest Rapamycin longevity trial in humans which will very soon be completed.

010

Krister Kauppi - Rapamycin Longevity Lab @kristerkauppi.bsky.social · 07/11/2023

The roadmap for the Rapamycin Longevity Lab is taking shape. It's time to start moving the field forward in a big way 🙏

011

Krister Kauppi - Rapamycin Longevity Lab @kristerkauppi.bsky.social · 21/10/2023

Today I launched the first community-driven Rapamycin Longevity Lab which will start to move the field forward in a much faster and efficient way. We will start up two revolutionary projects together. You can find more info on the homepage. Link you can find in the comment below or on my profile.

121

Krister Kauppi - Rapamycin Longevity Lab @kristerkauppi.bsky.social · 18/10/2023

In the Rapamycin Longevity Series I interview the world's leading longevity researcher Brian Kennedy. He is currently leading a huge and unique research project in Singapore where he together with his team is creating an efficient pipeline for validating longevity interventions in humans.

youtube.com

Brian Kennedy on Rapamycin Master Series | Aging is the biggest risk factor for age-related diseases

Professor Brian Kennedy from the National University of Singapore is one of the world's leading researchers in the longevity field and has done longevity res...

050